---
$id: https://graph.org.ai/products/commodity/51152051
$type: Product
source: UNSPSC
code: "51152051"
title: "Cisatracurium besilate"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cisatracurium besilate

**UNSPSC Code**: 51152051
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nicotinic antagonist with the molecular formula C53H72N2O12.2C6H5O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 80YS8O1MBS, chemically known as isoquinolinium, 2,2-(1,5-pentanediylbis(oxy(3-oxo-3,1-propanediyl)))bis(1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, dibenzenesulfonate, (1r-(1alpha,2alpha(1r(sup *),2r(sup *))))- but more generally known as cisatracurium besilate, which bears US NIH Compound Identifier 62886. European Medicines Agency schedules Cisatracurium besilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07480MIG. The term CISATRACURIUM BESILATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 10, No. 3, 1996, List 36). Most nations, for tariff and trade purposes, schedule cisatracurium besilate under HS 29334990 and SITC 51575. SMILES: C[N@@+]1(CCC2CC(C(CC2[C@H]1CC3CCC(C(C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@+]4(CCC5CC(C(CC5[C@H]4CC6CCC(C(C6)OC)OC)OC)OC)C.C1CCC(CC1)S(=O)(=O)[O-].C1CCC(CC1)S(=O)(=O)[O-].

